Liraglutide vs. Semaglutide: A Practical Comparison

Liraglutide and semaglutide are both GLP-1 receptor agonists. They are related, but they are not identical.

Semaglutide is often discussed because weekly products have shown strong average weight-loss results in clinical studies. Liraglutide is a once-daily medication with established FDA-approved uses and, now, generic options. The right question is not simply "Which one is stronger?" It is "Which option is appropriate, accessible, FDA-approved, and realistic for me?"

Dosing frequency

Liraglutide is taken once daily. Semaglutide injection products for weight management are generally taken once weekly.

Weekly dosing can be convenient. Daily dosing can still work well for people who build it into a consistent routine. Your clinician can discuss how dosing frequency fits your habits, travel, storage needs, and follow-up plan.

Weight-loss expectations

In head-to-head and comparative research, semaglutide has often produced greater average weight loss than liraglutide. That is important, but averages are not individual predictions.

People stop medications for different reasons: side effects, cost, access, medical contraindications, or preference. A medication that looks best in a chart may not be best for a specific patient.

Cost and access

Cost is one of the biggest reasons patients search for alternatives. Brand-name GLP-1 medications can be expensive and may not be covered by insurance for every indication.

That demand helped drive growth in compounded GLP-1 offers online. But compounded semaglutide is not FDA-approved. The FDA has warned about compounded GLP-1 issues, including dosing errors and misleading marketing.

FDA-approved generic liraglutide can be a clearer alternative to discuss with a clinician because it is not compounded.

Safety considerations

Both liraglutide and semaglutide can cause gastrointestinal side effects. Both require medical review. GLP-1 medications may not be appropriate for people with certain personal or family medical histories.

For liraglutide specifically, labeling includes a boxed warning about thyroid C-cell tumors and contraindications for people with personal or family history of medullary thyroid carcinoma or MEN 2.

Do not choose a GLP-1 based on social media alone. Your medication history, current prescriptions, and health conditions matter.

The compounded-medication trap

Many online comparisons quietly compare FDA-approved liraglutide with compounded semaglutide as if both are simply "GLP-1 options." That is not a fair comparison.

FDA-approved medication and compounded medication are different categories. The FDA has emphasized that compounded drugs are not FDA-approved and are not the same as generic drugs.

If you are comparing options, ask:

• Is the semaglutide FDA-approved brand-name medication?
• Is it compounded?
• Is the liraglutide FDA-approved generic?
• Which pharmacy dispenses it?
• What is the full monthly cost?

Where ClearDay fits

ClearDay is not trying to be every GLP-1 program. It focuses on one clear path: a $49 telehealth consult for FDA-approved generic liraglutide, reviewed by licensed U.S. clinicians, with medication dispensed by licensed pharmacies if prescribed.

No compounded GLP-1. No guessing what category the medication belongs to.

Sources

• FDA: Generic Drug Facts - https://www.fda.gov/drugs/generic-drugs/generic-drug-facts
• FDA: Concerns with unapproved GLP-1 drugs - https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
• FDA: Saxenda prescribing information - https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/206321s025lbl.pdf
• JAMA: Weekly semaglutide vs daily liraglutide in adults with overweight or obesity - https://pmc.ncbi.nlm.nih.gov/articles/PMC8753508/

This article is for general information only and is not medical advice. A licensed clinician must determine whether any prescription medication is appropriate.